Evidence map›Paper›PMID 36341110›Full record

ArticleFrontiers in neurology2022

The impact of COVID-19 pandemic on treatment delay and short-term neurological functional prognosis for acute ischemic stroke during the lockdown period.

Shiyuan Gu, Jie Li, Huachao Shen, Zhengze Dai, Yongjie Bai, Shuai Zhang, Hongyi Zhao, Suiyun Zhou, Yan Yu, Wuzhuang Tang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Increased time to surgery and worse perioperative outcome in benign brain tumor patients with COVID-19.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Shiyuan GuDepartment of Neurology, Affiliated Yixing Hospital of Jiangsu University, Yixing, China.
Jie LiDepartment of Neurology, Affiliated Yixing Hospital of Jiangsu University, Yixing, China.
Huachao ShenDepartment of Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Zhengze DaiDepartment of Neurology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing Pukou Hospital, Nanjing, China.
Yongjie BaiDepartment of Neurology, First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China.
Shuai ZhangDepartment of Neurology, Affiliated Hospital of Yangzhou University, Yangzhou, China.
Hongyi ZhaoDepartment of Neurology, No. 984 Hospital of PLA, Beijing, China.
Suiyun ZhouDepartment of Neurology, Affiliated Yixing Hospital of Jiangsu University, Yixing, China.
Yan YuDepartment of Neurology, Affiliated Yixing Hospital of Jiangsu University, Yixing, China.
Wuzhuang TangDepartment of Neurology, Affiliated Yixing Hospital of Jiangsu University, Yixing, China.
Yixing People's Hospital · CNJiangsu University · CNFirst Affiliated Hospital of Henan University of Science and Technology · CNNanjing General Hospital of Nanjing Military Command · CNPLA 306 Hospital · CNSecond Affiliated Hospital of Nanjing Medical University · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Preventive strategies implemented during the COVID-19 pandemic may negatively influence the management of patients with acute ischemic stroke (AIS). Nowadays, studies have demonstrated that the pandemic has led to a delay in treatment among patients with AIS. Whether this delay contributes to meaningful short-term outcome differences warranted further exploration. Objective: The objective of this study was to evaluate the impacts of the COVID-19 pandemic on treatment delay and short-term outcomes of patients with AIS treated with IVT and MT. Methods: Patients admitted before (from 11/1/2019 to 1/31/2020) and during the COVID-19 pandemic (from 2/1/2020 to 3/31/2020) were screened for collecting sociodemographic data, medical history information, and symptom onset status, and comparing the effect of treatment delay. The patients treated with IVT or MT were compared for delay time and neurological outcomes. Multivariable logistic regression was used to estimate the effect of treatment delay on short-term neurological prognosis. Results: In this study, 358 patients receiving IVT were included. DTN time increased from 50 min (IQR 40-75) before to 65 min (IQR 48-84), Conclusion: The COVID-19 pandemic has had remarkable impacts on the management of AIS. The pandemic might exacerbate certain time delays and play a significant role in early adverse outcomes in patients with AIS.

Indexed as

acute strokeCOVID-19intravenous thrombolysismechanical thrombectomytreatment delay

Identifiers

PMID36341110
PMCPMC9630364
OpenAlexW4306929750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.